New lupus shot tested for safety in small trial
NCT ID NCT06955598
First seen Jan 04, 2026 · Last updated May 21, 2026 · Updated 22 times
Summary
This early-stage study tested a new drug called SHR-2173 in 30 adults with systemic lupus erythematosus (SLE). The main goal was to see if multiple injections under the skin are safe and how the drug moves through the body. Participants received the drug and were monitored for side effects. This is not a cure; it is a first step to see if the drug is safe enough for larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Renji Hospital affiliated to Shanghai Jiaotong
Shanghai, Shanghai Municipality, 200000, China
Conditions
Explore the condition pages connected to this study.